Cambridge, MA, United States of America

Lysosomal Therapeutics Inc.


USPTO Granted Patents = 7



Forward Citations = 101

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Renato T Skerlj (7 out of 28 patents)

silverMedal Peter T Lansbury (7 out of 23 patents)

bronzeMedal Elyse Marie Josee Bourque (6 out of 23 patents)

4 Andrew Charles Good (3 out of 58 patents)

5 Jianbin Zheng (1 out of 11 patents)

6 Richard B Silverman (1 out of 106 patents)

7 Dimitri Krainc (1 out of 14 patents)

8 Elyse Marie Josee Bourque (0 patent)

9 Elyse Marie Josée Bourque (0 patent)


7 patents:

Lysosomal Therapeutics Inc. is a biotechnology company focused on the development of novel small molecules for the treatment of neurodegenerative diseases. Their proprietary technology platform targets lysosomal enzyme deficiencies, with the potential to address a variety of rare and common neurological disorders. Lysosomal Therapeutics Inc. is committed to advancing innovative therapeutics that have the potential to improve the lives of patients.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

7 Patents

#267 in Cambridge, MA

#2,239 in Massachusetts

#38,743 in US

...
Cambridge, MA, United States of America
Forward Citations = 101

9 inventors:

Please report any incorrect information to support@idiyas.com
Loading…